CroíValve adds $20m to Series B, taking round to $36m
European medtech innovation is gaining significant traction, as exemplified by CroíValve's bolstered Series B funding round. This substantial investment underscores investor confidence in the region's capacity to foster groundbreaking digital health solutions, particularly those addressing critical unmet medical needs. The expansion of this funding round highlights a growing appetite for European companies at the forefront of medical technology and digital transformation within healthcare. The recent injection of $20 million, bringing the total Series B round to $36 million, will primarily fuel an expanded clinical study for CroíValve's Duo Tricuspid Coaptation Valve System across the US and EU. This advanced digital health device aims to revolutionize the treatment of tricuspid regurgitation, a common and often serious heart valve condition. The system’s development leverages sophisticated digital modeling and potentially advanced material science, positioning it as a key player in the future of cardiovascular care. This development directly impacts patients suffering from tricuspid regurgitation by offering a potentially life-changing treatment option, alongside the healthcare providers who will implement this new technology. Furthermore, it strengthens Europe's competitive edge in the global digital health market, demonstrating a commitment to fostering domestic innovation and reducing reliance on external technological solutions in critical sectors. The success of such ventures paves the way for further investment and development in European digital health ecosystems.
Curated and translated by Europe Digital for our multilingual European audience.
Why this matters for European digital sovereignty
CroíValve's expanded Series B funding round showcases strong investor confidence in European medtech innovation, particularly in digital health solutions for critical medical needs. This investment will support a US and EU clinical study for their novel digital health device, strengthening Europe's competitive position in the global digital health market. The development highlights a growing European appetite for companies leading digital transformation in healthcare.
Source Information
European Alternatives You Might Like
Mangopay
Mangopay is a payment infrastructure provider specializing in payments for marketplaces and platforms. It offers virtual wallet technology for managing funds, enabling features such as split payments, multi-currency support, and KYC/AML compliance. Key functionalities include automated payouts, transaction monitoring, and customizable payment flows. This service is primarily aimed at businesses that manage marketplaces, crowdfunding platforms, and sharing economy models and require complex payment solutions. Mangopay distinguishes itself by offering a flexible and scalable payment solution specifically designed for platform-based business models, allowing them to control cash flows and streamline payment processes.
Scaleway
Scaleway is a European cloud computing provider offering a range of services, including servers, storage, and networking solutions. Key features include bare metal servers, virtual machines, object storage, and managed Kubernetes. It's suitable for developers, startups, and businesses seeking cloud infrastructure for web applications, data storage, and various other workloads. Scaleway distinguishes itself through competitive pricing and a focus on European data sovereignty, with data centers in France and the Netherlands.